Aesthetic Medicine Market Report 2026

The aesthetic medicine market size has grown strongly in recent years. It will grow from $73.7 billion in 2025 to $80.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growing awareness of cosmetic procedures, technological limitations in non-invasive devices, high cost of surgical procedures, limited accessibility to professional aesthetic services, lack of standardization in aesthetic medicine practices.

The aesthetic medicine market size is expected to see strong growth in the next few years. It will grow to $110.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to innovation in non-invasive technologies, increasing adoption of AI-driven treatment planning, rise in disposable income and cosmetic spending, expansion of medical aesthetic infrastructure in emerging regions, personalized and precision aesthetic treatments. Major trends in the forecast period include rise of minimally invasive procedures, growth of non-surgical cosmetic treatments, increasing demand for personalized aesthetic solutions, expansion of medical spas and beauty clinics, technological advancements in skin and hair devices.

Rapid urbanization and rising disposable incomes are expected to drive the growth of the aesthetic medicine market in the forecast period. Higher disposable incomes increase consumer spending on personal care, making high-end aesthetic treatments more accessible. Simultaneously, urban populations are increasingly appearance-conscious, further boosting demand for aesthetic procedures. For instance, the United Nations projects that by 2050, around 68% of the global population will reside in urban areas, up from 55% currently. Additionally, Fitch Solutions estimates that personal care and cosmetics spending will reach IDR 3.8 trillion ($45.3 billion) in 2026, growing at an average annual rate of 11.8% from IDR 2.52 trillion ($33.3 billion) in 2022. These trends indicate that urbanization and higher disposable income will continue to propel market growth.

Key companies in the aesthetic medicine sector are advancing technologies such as next‑generation RF microneedling systems to provide minimally invasive skin rejuvenation, collagen stimulation, and skin tightening with reduced downtime. RF microneedling combines microneedling with radiofrequency energy, creating micro-channels while delivering RF energy to the dermis, enhancing collagen and elastin production more effectively and with less discomfort than traditional laser resurfacing. For example, in July 2024, Crescita Therapeutics, a Canada-based medical device company, launched the MicronJet 600. Using MEMS (micro-electromechanical systems) technology, this intradermal delivery system allows virtually pain-free injections with precise targeting of the dermal layer, improving treatment outcomes for applications such as skin remodeling, anti-aging, and scar therapy.

In September 2024, ARCHIMED, a France-based private equity firm, acquired Jeisys Medical, a South Korea-based aesthetic medicine manufacturer. This acquisition aims to support Jeisys Medical’s expansion in the non-invasive aesthetic medicine market and facilitate its delisting from the Korea Exchange.

Major companies operating in the aesthetic medicine market are AbbVie, Johnson & Johnson, Galderma, Bausch Health, Shanghai Fosun Pharmaceutical Co, Cynosure, El.En. S.p.A, Cutera, Merz Pharma, Syneron Candela, Vive Cosmetics, VLCC Personal Care, Kazima Cosmetics, SoftFil, Sinclair Pharma, BIOXIS Pharmaceuticals, Premium Aesthetics LLC, Martinex, Medical Esthetic, Ipsen Pharma, Ruby Surgery & Aesthetics, Medicina Estética Regenerativa, Xcite Technologies, ReNue Aesthetic Medicine, VYDENCE Medical, Julphar, Aspen Pharmacare, Altis Biologics, Cipla Medpro, Sanofi Genzyme.

North America was the largest region in the aesthetic medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aesthetic medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aesthetic medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the aesthetic medicine market by increasing the cost of imported medical devices and consumables used for non-invasive procedures, cosmetic implants, and skin treatments. The rise in production and import costs has affected segments such as body contouring devices, laser hair removal devices, and facial aesthetic products, particularly in North America and Europe, where dependence on imported equipment is high. While tariffs may create short-term cost pressures, they encourage local manufacturing and innovation, potentially boosting domestic production capabilities and the development of cost-efficient aesthetic solutions.

The aesthetic medicine market research report is one of a series of new reports that provides aesthetic medicine market statistics, including aesthetic medicine industry global market size, regional shares, competitors with a aesthetic medicine market share, detailed aesthetic medicine market segments, market trends and opportunities, and any further data you may need to thrive in the aesthetic medicine industry. This aesthetic medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Aesthetic medicine is a growing medical field distinct from plastic surgery, offering minimally invasive procedures to enhance patients’ satisfaction with their physical appearance. These elective treatments are performed on healthy adult patients. Procedures include non-invasive lipolysis, hair restoration and removal, cellulite reduction, wrinkle reduction, skin renewal and resurfacing, and more.

The main products in aesthetic medicine include facial aesthetic products, body contouring devices, cosmetic implants, hair removal devices, skin aesthetic devices, and others. Facial aesthetic products are used in non-surgical facial treatments, such as Botox, fillers, and anti-wrinkle injections. Procedures in aesthetic medicine can be invasive or non-invasive and are performed in clinics, hospitals, medical spas, beauty centers, and home care settings.

The aesthetic medicine market consists of sales of chemical peels, cosmetic dermatology treatments, dermal fillers, and hair transplants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.